School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

BELITE BIO, INC BLTE

Healthcare · Biotechnology

$154.49last close 2026-10-09 · market cap $6.22B · delayed data

Trailing returns

1M-15.65%
3M+0.82%
6M-14.73%
1Y+96.80%

Basis: Adjusted daily closes.

What it does

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.

Open BLTE in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies